307 related articles for article (PubMed ID: 10168035)
1. Sumatriptan. A pharmacoeconomic review of its use in migraine.
Coukell AJ; Lamb HM
Pharmacoeconomics; 1997 May; 11(5):473-90. PubMed ID: 10168035
[TBL] [Abstract][Full Text] [Related]
2. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
4. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine.
Mushet GR; Miller D; Clements B; Pait G; Gutterman DL
Headache; 1996 Mar; 36(3):137-43. PubMed ID: 8984084
[TBL] [Abstract][Full Text] [Related]
5. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Lofland JH; Kim SS; Batenhorst AS; Johnson NE; Chatterton ML; Cady RK; Kaniecki R; Nash DB
Mayo Clin Proc; 2001 Nov; 76(11):1093-101. PubMed ID: 11702897
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
Plosker GL; McTavish D
Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
[TBL] [Abstract][Full Text] [Related]
8. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009665. PubMed ID: 22336869
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
12. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
13. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
14. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine.
Biddle AK; Shih YC; Kwong WJ
Pharmacotherapy; 2000 Nov; 20(11):1356-64. PubMed ID: 11079284
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Zhang L; Hay JW
CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
[TBL] [Abstract][Full Text] [Related]
17. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
Dechant KL; Clissold SP
Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
[TBL] [Abstract][Full Text] [Related]
19. Costs and outcomes of early versus delayed migraine treatment with sumatriptan.
Halpern MT; Lipton RB; Cady RK; Kwong WJ; Marlo KO; Batenhorst AS
Headache; 2002; 42(10):984-99. PubMed ID: 12453030
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
